Dividends & Bonus Issues This Week (Nov 24–28, 2025): HDFC AMC, Thyrocare, PFC, Ingersoll Rand & More

With the year closing in, companies are actively rewarding shareholders through bonus issues and interim dividends. This week features key announcements from major listed companies, giving investors an opportunity to review their portfolios and track important record dates.

Bonus Issues This Week (Nov 24–28, 2025)

Two prominent companies have announced bonus shares this week. Bonus issues increase the number of shares held without changing the total investment value, often improving liquidity and market participation.

What it means for shareholders:

• HDFC AMC (1:1) → 1 bonus share for every 1 share held
• Thyrocare (2:1) → 2 bonus shares for every 1 share held

Dividend Announcements This Week

Note: Shareholders must hold these stocks in their demat account as of the record date to be eligible for dividends.

Read more: Stocks to Watch Today on 24 November 2025: IndiGo, Kotak Bank, Adani Green, and Others.

Infosys Buyback Program in Focus

Infosys has moved forward with its largest-ever ₹18,000 crore share buyback to boost shareholder value. Infosys shareholders holding the stock as of 14 November 2025 are eligible to participate.

The tender offer window runs from 20 November to 26 November 2025, giving investors a defined period to submit their shares. The buyback will be executed at a price of ₹1,800 per share, covering up to 10 crore shares (≈2.41% of paid-up equity capital).

Read more: Infosys Buyback: How Much Tax Will You Pay on The Buyback Amount?

Conclusion

This is an impactful week for shareholders, with significant corporate actions from companies like HDFC AMC, Thyrocare, PFC, and Ingersoll Rand. Investors may find this a strategic time to reassess the holdings in their Demat account, especially if looking for income opportunities or adjusting portfolios ahead of year-end.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.